By Gary Finnegan

1. New Transparency Efforts by Industry

Pharmaceutical firms will publish details of “transfers of value” to health professionals as part of a new industry-wide transparency drive for the first time in 2016. Read more …


2. Full Disclosure Required

Medicines companies will soon publish details of fees and travel grants paid to doctors, which is a chance to explain how experts help to shape education and drug development, writes Gary Finnegan Read More…


Related News from The Irish Times:
Pharma firms’ payments to doctors to be disclosed 


Gary Finnegan is a former Editor of IMN and the Irish winner of the EU Health Prize for Journalists in 2009, 2010,  and 2011. He was the 2013 winner of the GSK Medical Media Award ‘Professional medical media – opinion’